...discovery deal with J&J Insilico Medicine Inc. entered into a multitarget drug discovery agreement with Janssen Pharmaceutica...

...will become CMO, a newly created position. Before joining the autoimmune company, he served Basilea Pharmaceutica Ltd....

...Behind roluperidone, Minerva’s pipeline includes seltorexant (MIN-202), an OX2R antagonist. The biotech and the Janssen Pharmaceutica...

...presentation at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO), Basilea Pharmaceutica Ltd....
...factor β BioCentury Staff TeneoBio Inc. Institut Curie Institut National de la Sante et de la Recherche Medicale (INSERM) NIH Basilea Pharmaceutica Ltd. Integrin...

...therapies, as well as regenerative medicine. Janssen declines option for Provention Crohn's disease candidate Janssen Pharmaceutica...

...Minerva is leading development for insomnia, and co-developing the compound for depression with J&J’s Janssen Pharmaceutica...

...Pain company Neumentum Inc. licensed global rights to JNJ-10450232 and backup compounds from the Janssen Pharmaceutica...

...Learning Ledger Orchestration for Drug Discovery), includes 17 partners from across Europe with the Janssen Pharmaceutica...

...Forge and Basilea Pharmaceutica International Ltd. partnered to discover, develop and commercialize antibiotics against two undisclosed...
...royalties. Basilea Pharmaceutica International Ltd. is a subsidiary of Basilea Pharmaceutica Ltd. (SIX:BSLN). Shannon Lehnbeuter, Staff Writer Basilea Pharmaceutica Ltd. Forge...

...Eva-Maria Joed, who will become VP of finance and administration. Spota was CFO at Basilea Pharmaceutica...